The role of the microbiota in the management of intensive care patients
Abstract The composition of the gut microbiota is highly dynamic and changes according to various conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence knowledge about its composition has significantly arisen from culture-independent methods based on next-ge...
| Published in: | Annals of Intensive Care |
|---|---|
| Main Authors: | Piotr Szychowiak, Khanh Villageois-Tran, Juliette Patrier, Jean-François Timsit, Étienne Ruppé |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13613-021-00976-5 |
Similar Items
Modern approaches to the correction of the gut microbiota
by: N. V. Sturov, et al.
Published: (2021-04-01)
by: N. V. Sturov, et al.
Published: (2021-04-01)
Gastrointestinal Microbiome – What We Need to Know in Clinical Practice
by: Raquel Ortigão, et al.
Published: (2020-01-01)
by: Raquel Ortigão, et al.
Published: (2020-01-01)
Early-life microbiota-immune homeostasis
by: Hayley M. Reynolds, et al.
Published: (2023-10-01)
by: Hayley M. Reynolds, et al.
Published: (2023-10-01)
Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults
by: Iulia-Magdalena Vasilescu, et al.
Published: (2022-01-01)
by: Iulia-Magdalena Vasilescu, et al.
Published: (2022-01-01)
Next Generation Fecal Microbiota Transplantation
by: Tae-Geun Gweon, et al.
Published: (2021-03-01)
by: Tae-Geun Gweon, et al.
Published: (2021-03-01)
In vitro adhesion, pilus expression, and in vivo amelioration of antibiotic-induced microbiota disturbance by Bifidobacterium spp. strains from fecal donors
by: Aki Ronkainen, et al.
Published: (2023-12-01)
by: Aki Ronkainen, et al.
Published: (2023-12-01)
Gut Microbiota Manipulation in Irritable Bowel Syndrome
by: Tarek Mazzawi
Published: (2022-06-01)
by: Tarek Mazzawi
Published: (2022-06-01)
The Impact of Antibiotic Therapy on Intestinal Microbiota: Dysbiosis, Antibiotic Resistance, and Restoration Strategies
by: Gaia Cusumano, et al.
Published: (2025-04-01)
by: Gaia Cusumano, et al.
Published: (2025-04-01)
Commentary: Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
by: Blessing O. Anonye, et al.
Published: (2018-04-01)
by: Blessing O. Anonye, et al.
Published: (2018-04-01)
Fecal microbiota transplantation: a tale of two regulatory pathways
by: Diane E. Hoffmann, et al.
Published: (2025-12-01)
by: Diane E. Hoffmann, et al.
Published: (2025-12-01)
Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review
by: Mehdi Karimi, et al.
Published: (2024-09-01)
by: Mehdi Karimi, et al.
Published: (2024-09-01)
Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection
by: Pei-Chang Lee, et al.
Published: (2022-09-01)
by: Pei-Chang Lee, et al.
Published: (2022-09-01)
The Role of Fecal Microbiota Transplantation in IBD
by: Fabrizio Fanizzi, et al.
Published: (2024-08-01)
by: Fabrizio Fanizzi, et al.
Published: (2024-08-01)
Fecal microbiota transplantation for ulcerative colitis
by: Katsuyoshi Matsuoka
Published: (2021-01-01)
by: Katsuyoshi Matsuoka
Published: (2021-01-01)
Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection
by: Shaodong Wei, et al.
Published: (2022-12-01)
by: Shaodong Wei, et al.
Published: (2022-12-01)
Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients
by: Shinta Mizuno, et al.
Published: (2017-01-01)
by: Shinta Mizuno, et al.
Published: (2017-01-01)
Potential therapeutic solution for Clostridioides difficile infection: Current scenario and future prospects
by: Chandrashekhar Singh, et al.
Published: (2025-06-01)
by: Chandrashekhar Singh, et al.
Published: (2025-06-01)
Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
by: Hyuk Yoon, et al.
Published: (2021-01-01)
by: Hyuk Yoon, et al.
Published: (2021-01-01)
Research progress on fecal microbiota transplantation in tumor prevention and treatment
by: Wu Yijia, et al.
Published: (2025-04-01)
by: Wu Yijia, et al.
Published: (2025-04-01)
Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
by: Chang Mo Moon, et al.
Published: (2021-03-01)
by: Chang Mo Moon, et al.
Published: (2021-03-01)
The Microbiota–Human Health Axis
by: Harrie Toms John, et al.
Published: (2025-04-01)
by: Harrie Toms John, et al.
Published: (2025-04-01)
Ovariectomy-Induced Dysbiosis May Have a Minor Effect on Bone in Mice
by: Satoshi Kosaka, et al.
Published: (2021-12-01)
by: Satoshi Kosaka, et al.
Published: (2021-12-01)
The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics
by: Moshe Maor, et al.
Published: (2025-12-01)
by: Moshe Maor, et al.
Published: (2025-12-01)
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation
by: Ruiqiao He, et al.
Published: (2022-12-01)
by: Ruiqiao He, et al.
Published: (2022-12-01)
The central role of the gut in intensive care
by: Alberto Corriero, et al.
Published: (2022-12-01)
by: Alberto Corriero, et al.
Published: (2022-12-01)
Normalization of short-chain fatty acid concentration by bacterial count of stool samples improves discrimination between eubiotic and dysbiotic gut microbiota caused by Clostridioides difficile infection-
by: Anna Sayol-Altarriba, et al.
Published: (2024-12-01)
by: Anna Sayol-Altarriba, et al.
Published: (2024-12-01)
Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
by: Chun-Wei Chiu, et al.
Published: (2021-05-01)
by: Chun-Wei Chiu, et al.
Published: (2021-05-01)
Clostridioides difficile and neurological disorders: New perspectives
by: Manuele Biazzo, et al.
Published: (2022-09-01)
by: Manuele Biazzo, et al.
Published: (2022-09-01)
Advancing prostate cancer treatment: the role of fecal microbiota transplantation as an adjuvant therapy
by: Rasoul Ebrahimi, et al.
Published: (2025-01-01)
by: Rasoul Ebrahimi, et al.
Published: (2025-01-01)
Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
by: Carlo Airola, et al.
Published: (2023-05-01)
by: Carlo Airola, et al.
Published: (2023-05-01)
The concept of superdonor and other possible factors for the effectiveness of fecal microbiota transplantation
by: S.M. Tkach, et al.
Published: (2020-08-01)
by: S.M. Tkach, et al.
Published: (2020-08-01)
Case Report: Oral and fecal microbiota in a super-donor: the healthy microbiota paradigm for fecal transplantation
by: Nayeli Ortiz-Olvera, et al.
Published: (2023-09-01)
by: Nayeli Ortiz-Olvera, et al.
Published: (2023-09-01)
Prevention and treatment of Clostridium difficile infection
by: Gianenrico Rizzatti, et al.
Published: (2017-12-01)
by: Gianenrico Rizzatti, et al.
Published: (2017-12-01)
The Role of Gut Microbiota in Neurodegenerative Diseases
by: Hanna Porwolik, et al.
Published: (2025-01-01)
by: Hanna Porwolik, et al.
Published: (2025-01-01)
<i>Clostridioides difficile</i> in Peripartum Women: Review of Outcomes and Treatment
by: Ravina Kullar, et al.
Published: (2025-08-01)
by: Ravina Kullar, et al.
Published: (2025-08-01)
Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study
by: Tae-Geun Gweon, et al.
Published: (2023-01-01)
by: Tae-Geun Gweon, et al.
Published: (2023-01-01)
Role of microbiota in pain: From bench to bedside
by: Huiguang Ren, et al.
Published: (2025-03-01)
by: Huiguang Ren, et al.
Published: (2025-03-01)
Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
by: Shaaz Fareed, et al.
Published: (2018-05-01)
by: Shaaz Fareed, et al.
Published: (2018-05-01)
Fecal Microbiota Transplantation for Refractory and Recurrent Clostridium difficile Infection: A Case Series of Nine Patients
by: Byoung Wook Bang, et al.
Published: (2017-04-01)
by: Byoung Wook Bang, et al.
Published: (2017-04-01)
The effect of fecal microbiota transplantation on antibiotic-associated diarrhea and its impact on gut microbiota
by: Le Wang, et al.
Published: (2024-05-01)
by: Le Wang, et al.
Published: (2024-05-01)
Similar Items
-
Modern approaches to the correction of the gut microbiota
by: N. V. Sturov, et al.
Published: (2021-04-01) -
Gastrointestinal Microbiome – What We Need to Know in Clinical Practice
by: Raquel Ortigão, et al.
Published: (2020-01-01) -
Early-life microbiota-immune homeostasis
by: Hayley M. Reynolds, et al.
Published: (2023-10-01) -
Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults
by: Iulia-Magdalena Vasilescu, et al.
Published: (2022-01-01) -
Next Generation Fecal Microbiota Transplantation
by: Tae-Geun Gweon, et al.
Published: (2021-03-01)
